Live feed
Filing
SC 13D/A
SC 13D/A0001171520-22-000347·GYRE THERAPEUTICS, INC.
Schedule 13D ownership disclosure
CATALYST BIOSCIENCES INC
Security class unavailable · CUSIP: 14888D208
Event date: 2022-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171520-22-000347
- Form type
- SC 13D/A
- Filer
- GYRE THERAPEUTICS, INC.
- CIK
- CIK 1124105
- Filed
- May 25, 2022
- Reporting period
- May 24, 2022
- Description
- Schedule 13D beneficial ownership